Pfizer recently announced that its epilepsy drug Lyrica (pregabalin), failed to meet primary endpoint in Phase III study, assessing it as adjunctive therapy in epilepsy patients (aged 5 to 65 years) with primary generalized tonic-clonic (“PGTC”) seizures reports Yahoo...
87 people a day are diagnosed with epilepsy in the United Kingdom (UK)—this equals 600,000 people. With the diagnosis comes other conditions such as the possibility of memory loss and other cognitive issues. A new study led by the University of Liverpool and Alder...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
